FAS Wealth Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-6,005
| Closed | -$327K | – | 414 |
|
2022
Q2 | $327K | Buy |
6,005
+184
| +3% | +$10K | 0.03% | 225 |
|
2022
Q1 | $317K | Buy |
5,821
+53
| +0.9% | +$2.89K | 0.03% | 229 |
|
2021
Q4 | $318K | Sell |
5,768
-14,047
| -71% | -$774K | 0.03% | 241 |
|
2021
Q3 | $946K | Sell |
19,815
-286
| -1% | -$13.7K | 0.09% | 131 |
|
2021
Q2 | $1M | Buy |
20,101
+299
| +2% | +$14.9K | 0.09% | 128 |
|
2021
Q1 | $883K | Sell |
19,802
-454
| -2% | -$20.2K | 0.09% | 133 |
|
2020
Q4 | $932K | Buy |
20,256
+616
| +3% | +$28.3K | 0.11% | 121 |
|
2020
Q3 | $924K | Buy |
19,640
+670
| +4% | +$31.5K | 0.13% | 118 |
|
2020
Q2 | $967K | Sell |
18,970
-4
| -0% | -$204 | 0.14% | 106 |
|
2020
Q1 | $899K | Buy |
18,974
+4,555
| +32% | +$216K | 0.16% | 100 |
|
2019
Q4 | $847K | Buy |
14,419
+123
| +0.9% | +$7.23K | 0.14% | 105 |
|
2019
Q3 | $763K | Buy |
14,296
+565
| +4% | +$30.2K | 0.14% | 103 |
|
2019
Q2 | $687K | Buy |
13,731
+397
| +3% | +$19.9K | 0.13% | 113 |
|
2019
Q1 | $697K | Buy |
13,334
+129
| +1% | +$6.74K | 0.14% | 109 |
|
2018
Q4 | $631K | Buy |
13,205
+106
| +0.8% | +$5.07K | 0.14% | 107 |
|
2018
Q3 | $658K | Buy |
13,099
+123
| +0.9% | +$6.18K | 0.15% | 88 |
|
2018
Q2 | $654K | Buy |
12,976
+48
| +0.4% | +$2.42K | 0.18% | 85 |
|
2018
Q1 | $631K | Buy |
12,928
+136
| +1% | +$6.64K | 0.18% | 88 |
|
2017
Q4 | $567K | Sell |
12,792
-792
| -6% | -$35.1K | 0.15% | 100 |
|
2017
Q3 | $689K | Buy |
13,584
+1,311
| +11% | +$66.5K | 0.19% | 80 |
|
2017
Q2 | $662K | Buy |
12,273
+128
| +1% | +$6.9K | 0.2% | 76 |
|
2017
Q1 | $640K | Sell |
12,145
-217
| -2% | -$11.4K | 0.2% | 75 |
|
2016
Q4 | $595K | Buy |
12,362
+2,276
| +23% | +$110K | 0.18% | 76 |
|
2016
Q3 | $544K | Buy |
10,086
+1,066
| +12% | +$57.5K | 0.18% | 73 |
|
2016
Q2 | $489K | Buy |
9,020
+206
| +2% | +$11.2K | 0.18% | 76 |
|
2016
Q1 | $447K | Buy |
8,814
+2,184
| +33% | +$111K | 0.23% | 54 |
|
2015
Q4 | $334K | Buy |
6,630
+392
| +6% | +$19.7K | 0.17% | 84 |
|
2015
Q3 | $300K | Buy |
6,238
+2,405
| +63% | +$116K | 0.17% | 74 |
|
2015
Q2 | $200K | Sell |
3,833
-197
| -5% | -$10.3K | 0.1% | 108 |
|
2015
Q1 | $232K | Sell |
4,030
-313
| -7% | -$18K | 0.12% | 88 |
|
2014
Q4 | $232K | Buy |
4,343
+6
| +0.1% | +$321 | 0.12% | 82 |
|
2014
Q3 | $249K | Sell |
4,337
-197
| -4% | -$11.3K | 0.14% | 74 |
|
2014
Q2 | $303K | Sell |
4,534
-492
| -10% | -$32.9K | 0.17% | 64 |
|
2014
Q1 | $336K | Buy |
5,026
+3
| +0.1% | +$201 | 0.23% | 53 |
|
2013
Q4 | $335K | Buy |
+5,023
| New | +$335K | 0.2% | 57 |
|